TP53 and laryngeal carcinoma: Caponio et al.33 adopted a computational approach to determining the influence of specific TP53 mutations on survival outcomes, identifying DNA-binding domain mutations as a poor prognostic factor in laryngeal cancers (but not other anatomical sub-sites).